Northwell Health

Northwell Launches $500 Million Initiative to Expand Pediatric Mental Health Services and Access to Care for Children and Teens

Retrieved on: 
Wednesday, November 8, 2023
Managed Care, Family, Philanthropy, Consumer, Mental Health, Hospitals, Teens, Fund Raising, Parenting, Children, Practice Management, Health, Mental, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Adolescence, Ageing, Education, Cohen, Korea Disease Control and Prevention Agency, Impossible, Zucker Hillside Hospital, MD, Hofstra University, Psychiatry, Island, Mental health, Research, Multimedia, Pediatrics, Donald, Disorder, Student, Hospital, Stigma, Blumenfeld, Suicide, Depression, Citi Field, Anxiety, Patient, Bed, Death, Transplant, Parent, Nursing, Northwell Health, Child

The future Child and Adolescent Mental Health Pavilion will be connected to Cohen Children’s Medical Center and Zucker Hillside Hospital , Northwell’s adult mental health facility, in Queens, NY.

Key Points: 
  • The future Child and Adolescent Mental Health Pavilion will be connected to Cohen Children’s Medical Center and Zucker Hillside Hospital , Northwell’s adult mental health facility, in Queens, NY.
  • The approximately 200,000-square-foot building will fully integrate physical and mental health care for children and serve as a destination program for patients across the country.
  • The initiative will bring together Northwell’s extensive expertise in children’s clinical care, mental health, leading-edge research, education and medical training to set a new standard for care.
  • This investment will break the archaic siloed approach in which physical health is addressed at one facility and mental health at another by fully integrating physical and mental health care for children.”
    Through Cohen Children’s Medical Center, Northwell currently operates pediatric behavioral health urgent care centers in Nassau and Suffolk counties.

Feinstein Institutes’ Dr. Kevin J. Tracey receives 2023 Hans Wigzell Research Foundation's Science Prize

Retrieved on: 
Thursday, November 2, 2023
Science, Health, Neurology, Research, Sequence, Feinstein Institutes for Medical Research, Inflammation, Karolinska Institute, Doctor of Philosophy, Rheumatoid arthritis, Biomedical sciences, Shock, Immunity, Neuroscience, Boston University, Neurosurgery, Death, Rockefeller University, Medical research, Hope, Nobel Committee, Vagus nerve stimulation, Reflex, Cytokine, Boston College, Royal Academies for Science and the Arts of Belgium, Northwell Health, Medicine, Credit, UNESCO Science Prize, Patient, Vagus nerve, Septic shock, Human, University Medical Center, BS, Laboratory, Travel, Olivia Wigzell, Chemistry, Survival, Education, Royal Academy of Arts, Water, Multimedia, Dana, Engineering, Rockefeller, Student, Dana Foundation, Sepsis, Inflammatory bowel disease, Nursing, Pharmaceutical industry, Medical device, MD

The Hans Wigzell Research Foundation today announced that Kevin J. Tracey, MD, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research , is the recipient of the 2023 Hans Wigzell Research Foundation’s Science Prize in recognition of his significant contributions to the fields of neuroscience and neuroimmunology.

Key Points: 
  • The Hans Wigzell Research Foundation today announced that Kevin J. Tracey, MD, president and CEO of Northwell Health’s Feinstein Institutes for Medical Research , is the recipient of the 2023 Hans Wigzell Research Foundation’s Science Prize in recognition of his significant contributions to the fields of neuroscience and neuroimmunology.
  • Dr. Tracey will travel to Stockholm, Sweden, to receive the prize, which includes $100,000, and deliver a lecture on December 1.
  • View the full release here: https://www.businesswire.com/news/home/20231102553265/en/
    Dr. Kevin J. Tracey has been named awardee of the 2023 Hans Wigzell Research Foundation's Science Prize.
  • “The prize is given to Dr. Tracey for his innovative discoveries of the mechanisms of how nerves transmit signals to stop inflammatory diseases,” said Hans Wigzell, MD, PhD, on behalf of the Hans Wigzell Research Foundation.

Dr. Kevin J. Tracey receives Hans Wigzell Research Foundation's Science Prize amounting to USD 100.000

Retrieved on: 
Thursday, November 2, 2023
Medical research, Feinstein Institutes for Medical Research, Vagus nerve stimulation, Inflammation, Doctor of Philosophy, Rheumatoid arthritis, Research, Northwell Health, Neuroscience, Value Partners (asset management), USD, Patient, Inflammatory bowel disease, Pharmaceutical industry, MD

STOCKHOLM, Nov. 2, 2023 /PRNewswire/ -- The Hans Wigzell Research Foundation (Hans Wigzells Forskningsstiftelse) awards its annual scientific prize to Kevin J. Tracey, MD, president and CEO, at the Feinstein Institutes for Medical Research.

Key Points: 
  • STOCKHOLM, Nov. 2, 2023 /PRNewswire/ -- The Hans Wigzell Research Foundation (Hans Wigzells Forskningsstiftelse) awards its annual scientific prize to Kevin J. Tracey, MD, president and CEO, at the Feinstein Institutes for Medical Research.
  • Dr. Tracey receives the prize of USD 100.000 for his contributions to the fields of neuroscience and neuroimmunology and his pioneering discoveries in vagus nerve stimulation, the inflammatory reflex and bioelectronic medicine.
  • Dr. Tracey's discovery of the body's "inflammatory reflex" – a neural circuit regulating inflammatory responses, is on of his most important achievements.
  • "The prize is given to Dr. Tracey for his innovative discoveries of the mechanisms of how nerves transmit signals to stop inflammatory diseases," said Hans Wigzell, MD, PhD, on behalf of the Hans Wigzell Research Foundation.

Damo Announces the Launch of the DigiM™ Digital Maturity Momentum Awards 2023

Retrieved on: 
Wednesday, October 25, 2023
Momentum, Digital, Virtua Health, University of Rochester Medical Center, Digital Solutions, Self-assessment, Intermountain Health, Organization, Exercise, Senior, Growth, Northwell Health, Ecosystem, University, Benchmarking, Nursing, Video game, Management, Entertainment, Sentara Healthcare

CHICAGO, Oct. 25, 2023 /PRNewswire-PRWeb/ -- Damo Consulting, a prominent player in healthcare digital transformation, is delighted to introduce the highly anticipated DigiM™ Digital Maturity Momentum Awards for 2023. These awards are a testament to the commitment and success of organizations and individuals in the ever-evolving landscape of digital transformation in healthcare.

Key Points: 
  • CHICAGO, Oct. 25, 2023 /PRNewswire-PRWeb/ -- Damo Consulting , a prominent player in healthcare digital transformation, is delighted to introduce the highly anticipated DigiM™ Digital Maturity Momentum Awards for 2023.
  • Last year , our inaugural DigiM™ Digital Maturity Momentum Awards program received an overwhelming response from health systems looking to conduct a self-assessment and compare themselves against their peers in digital transformation progress.
  • The DigiM™ Digital Maturity Momentum Awards are grounded in the DigiM™ Digital Maturity Framework, an invaluable tool for assessing and benchmarking digital maturity and progress within the realm of digital transformation.
  • Why the DigiM™ Digital Maturity Momentum Awards Matter:
    Recognition of Excellence: DigiM™ Award recipients are celebrated for their exceptional leadership in digital transformation, reflecting dedication and accomplishments in the field.

Northwell’s Dr. Jennifer H. Mieres Recognized Among Modern Healthcare's Top Diversity Leaders in Healthcare

Retrieved on: 
Monday, October 23, 2023
Human Resources, Women, Hospitals, Professional Services, Cardiology, Practice Management, DEI (Diversity, Equity and Inclusion), Health, Consumer, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Policy, Faculty, Modern Healthcare, Health equity, Human, MD, Hofstra University, American Heart Association, Organization, Research, Multimedia, United States at the 2022 World Games, The Human Connection, Partnership, Credit, Woman, Bias, Book, Cardiovascular disease, Nursing, Health care, Northwell Health

Northwell Health’s Jennifer H. Mieres, MD , senior vice president and chief diversity and inclusion officer, has been recognized as one of Modern Healthcare’s Top Diversity Leaders in Healthcare .

Key Points: 
  • Northwell Health’s Jennifer H. Mieres, MD , senior vice president and chief diversity and inclusion officer, has been recognized as one of Modern Healthcare’s Top Diversity Leaders in Healthcare .
  • This prestigious recognition highlights Dr. Mieres' exceptional contributions to promoting diversity and inclusion as foundational to advancing equity in care within the healthcare industry.
  • The profiles of all the winners are featured in the October 16, 2023 print issue of Modern Healthcare and here.
  • View the full release here: https://www.businesswire.com/news/home/20231023670633/en/
    Dr. Jennifer H. Mieres has been named one of Modern Healthcare’s 2023 Top Diversity Leaders.

Press Ganey partners with Northwell Health as the first site to launch its Patient Experience in Clinical Trials Standardized Measures Pilot Program

Retrieved on: 
Thursday, October 19, 2023
Technology, Consulting, Clinical Trials, Health Technology, Professional Services, Software, Health, General Health, Data Management, Press Ganey Associates, Friction, HX, Northwell Health, Human, Clinical research, Clinical trial, Patient, SVP, Pharmaceutical industry

Press Ganey, the renowned leader in transforming the Human Experience (HX) across the healthcare ecosystem, today announced they are partnering with Northwell Health, an integrated healthcare network and New York State's largest healthcare provider, for the validation of Press Ganey’s novel Patient Experience in Clinical Trials measures.

Key Points: 
  • Press Ganey, the renowned leader in transforming the Human Experience (HX) across the healthcare ecosystem, today announced they are partnering with Northwell Health, an integrated healthcare network and New York State's largest healthcare provider, for the validation of Press Ganey’s novel Patient Experience in Clinical Trials measures.
  • Clinical trials have long been plagued by challenges in recruitment, retention and diversity of patient participants, and patient feedback has been recognized as a key method for improving the patient journey.
  • By leveraging Press Ganey’s Human Experience platform, which includes HIPAA-compliant survey tools and expertise to improve retention and diversity in clinical trials, Northwell has spearheaded the extension of measurement into their Office of Clinical Research to further improve the Human Experience in healthcare while also accelerating the development of critical new medicines.
  • “Understanding the experiences of patients participating in clinical trials offered at Northwell will uncover key insights that will allow us to improve retention by acting on points of friction raised in real time,” said Dr. Christina Brennan, SVP, Clinical Research at Northwell Health.

Vagus nerve stimulation reduces inflammation in children with Inflammatory Bowel Disease, Feinstein Institutes study finds

Retrieved on: 
Wednesday, October 18, 2023
Research, Managed Care, General Health, Consumer, Medical Devices, Children, Science, Biotechnology, Neurology, Practice Management, Other Science, Health, Abdominal pain, Child, MRI, Medical research, Feinstein, Inflammation, Feinstein Institutes for Medical Research, Cohen, FC, Vagus nerve, Weatherall Institute of Molecular Medicine, Heart rate, Diarrhea, Human, Medicine, Prevalence, Vagus nerve stimulation, Incontinence, Diabetes, Rheumatoid arthritis, MBA, Electricity, TENS, Bleeding, GE Research, Ulcerative colitis, Multimedia, Northwell Health, Disease, Clinical trial, Nature Communications, Pulmonary hypertension, Neuroscience, Ear, Arthritis, IBD, Sickle Cell Anemia, a Molecular Disease, Credit, Molecular medicine, Brain, Cancer, Patient, Liver disease, Biomedical engineering, Bangladesh Technical Education Board, MS, Central nervous system, Lupus, Medical imaging, Pharmaceutical industry, Management, Gastroenterology, MD

View the full release here: https://www.businesswire.com/news/home/20231018401966/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231018401966/en/
    The Feinstein Institutes for Medical Research’s Dr. Benjamin Sahn led the vagus nerve stimulation clinical trial.
  • Inflammation and the inflammatory reflex – the neuronal signaling between the brain and body – is an important immune response.
  • Previous research and functional MRI studies have mapped stimulation of the auricular branch of the vagus nerve to activate the same brain regions as implanted devices, confirming this nerve as a suitable non-invasive target to administer vagus nerve stimulation.
  • Also, Feinstein Institutes researchers, in collaboration with GE Research, published research that harnessed ultrasound technology to reduce inflammation in the body non-invasively.

The Lupus Research Alliance Walk with Us to Cure Lupus Takes Off at the Intrepid Museum

Retrieved on: 
Friday, October 20, 2023
Montefiore Medical Center, Walking, NFL, Intrepid Sea, Air & Space Museum, Columbia University Irving Medical Center, National Football League Foundation, Therapy, Government, Lupus Research Alliance, RPW, Hospital for Special Surgery, NYU Langone Health, Research, Walking day, Lupus, LRA, Air and Space Museum, Northwell Health, Disease, Atmosphere of Earth, GSK, Autoimmune disease, Columbia University, KPMG, Walkers, Hospital, Pharmaceutical industry, Aurinia, Genentech

NEW YORK, Oct. 20, 2023 /PRNewswire/ -- Thousands of supporters will join together Saturday, October 21 at the Intrepid Museum (formerly called the Intrepid Sea, Air and Space Museum) to celebrate the 20th Anniversary of the Lupus Research Alliance (LRA) 2023 New York City Walk with Us to Cure Lupus.

Key Points: 
  • NEW YORK, Oct. 20, 2023 /PRNewswire/ -- Thousands of supporters will join together Saturday, October 21 at the Intrepid Museum (formerly called the Intrepid Sea, Air and Space Museum) to celebrate the 20th Anniversary of the Lupus Research Alliance (LRA) 2023 New York City Walk with Us to Cure Lupus.
  • That number is still climbing as Walkers continue to fundraise for lupus research.
  • Because the LRA's Board of Directors covers all administrative and fundraising costs, 100 percent of these donations go directly to lupus research programs.
  • Joining the Walk with Us to Cure Lupus program to raise funds is just one way to contribute to the lupus cause.

Englewood Health Appoints Two New Physician Leaders to Roles in Behavioral Health and Health Equity

Retrieved on: 
Thursday, October 19, 2023
American Diabetes Association, Psychiatry, University, Education, Endocrine Society, Health, American Psychiatric Association, Stanford University School of Medicine, MD, Maimonides Medical Center, Endocrinology, Diabetes, Metabolism, Saint Andrew's Society, Traumatic brain injury, Northwell Health, Health equity, Student, Internal medicine, Long Island, Cancer, Addiction medicine, Patient, Diagnosis, Mental health, Hospital, Pharmaceutical industry, Nursing, Medical device, Pharmacy

ENGLEWOOD, N.J., Oct. 19, 2023 /PRNewswire/ -- Englewood Health has appointed two new physician leaders to oversee behavioral health and health equity.

Key Points: 
  • ENGLEWOOD, N.J., Oct. 19, 2023 /PRNewswire/ -- Englewood Health has appointed two new physician leaders to oversee behavioral health and health equity.
  • "We are delighted to welcome Dr. Spariosu as director of behavioral health," says Hillary Cohen, MD, senior vice president for medical affairs at Englewood Health.
  • Under her leadership, Englewood Health will build on its success and further meet the behavioral health needs of our communities."
  • Under her guidance, Englewood Health will implement targeted interventions designed to improve health outcomes and health equity for our communities."

Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress

Retrieved on: 
Tuesday, October 10, 2023
Stroke, ElectroCore, ECOR, Northwell Health, Abstract, Research, NVN, Pharmaceutical industry

ROCKAWAY, N.J., Oct. 10, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced top line data from two abstracts being presented at the 15th World Stroke Congress held October 10-12, 2023, in Toronto, Canada on the possible role of nVNS in the treatment of acute neurological injuries.

Key Points: 
  • Our data suggests that nVNS is safe and effective in reducing pain and potentially the use of other acute pain medications, including opioids in the immediate aftermath of a SAH.
  • NOVIS is a prospective randomized clinical trial with blinded outcome assessment being conducted at the Leiden University Medical Center (Leiden, The Netherlands).
  • 150 patients with ischemic stroke are being randomly allocated (1:1) to nVNS for five days in addition to standard treatment versus standard treatment alone.
  • The strong mechanistic rational for nVNS as a potentially neuroprotective and anti-inflammatory treatment for acute neurological injury is further supported by this data showing the continued efficacy of nVNS for the treatment of pain.